Variant report

Variant	rs9366650
Chromosome Location	chr6:26335997-26335998
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr6:26285243..26287607-chr6:26335605..26337289,2	MCF-7	breast:
2	chr6:26335854..26338260-chr6:26521210..26523383,2	K562	blood:
3	chr6:26335137..26336681-chr6:26520330..26522569,2	K562	blood:
4	chr6:26332412..26338207-chr6:26594644..26597899,6	K562	blood:
5	chr6:26335002..26337224-chr6:27114575..27116248,2	K562	blood:
6	chr6:26334953..26336656-chr6:27103104..27105866,2	K562	blood:
7	chr6:26335002..26338978-chr6:27114071..27116381,5	K562	blood:

Variant related genes	Relation type
ENSG00000158406	Chromatin interaction
ENSG00000265565	Chromatin interaction
ENSG00000197903	Chromatin interaction
ENSG00000146109	Chromatin interaction
ENSG00000228223	Chromatin interaction
ENSG00000184825	Chromatin interaction

Extended variants
information (count: 39 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:29)

rs_ID	r²[population]
rs12525187	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs12660432	0.82[EUR][1000 genomes]
rs17608582	0.82[EUR][1000 genomes]
rs1883213	0.81[EUR][1000 genomes]
rs1987244	0.81[EUR][1000 genomes]
rs2893820	0.81[EUR][1000 genomes]
rs2893843	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs4412193	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs61324092	0.81[EUR][1000 genomes]
rs62394764	0.81[EUR][1000 genomes]
rs62394768	0.82[EUR][1000 genomes]
rs6908402	0.88[AMR][1000 genomes];0.93[EUR][1000 genomes]
rs6917995	0.81[ASN][1000 genomes]
rs6918325	0.82[EUR][1000 genomes]
rs6930616	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs725575	0.81[EUR][1000 genomes]
rs9357005	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs9358916	0.86[AFR][1000 genomes];0.90[AMR][1000 genomes];0.96[EUR][1000 genomes];0.83[ASN][1000 genomes]
rs9358918	0.88[AFR][1000 genomes];0.90[AMR][1000 genomes];0.96[EUR][1000 genomes];0.83[ASN][1000 genomes]
rs9358920	0.88[AFR][1000 genomes];0.92[AMR][1000 genomes];0.97[EUR][1000 genomes];0.80[ASN][1000 genomes]
rs9358925	0.82[EUR][1000 genomes]
rs9358927	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs9366648	0.80[EUR][1000 genomes]
rs9379842	0.88[AFR][1000 genomes];0.92[AMR][1000 genomes];0.97[EUR][1000 genomes];0.86[ASN][1000 genomes]
rs9379844	0.88[AFR][1000 genomes];0.92[AMR][1000 genomes];0.96[EUR][1000 genomes];0.86[ASN][1000 genomes]
rs9379846	0.82[EUR][1000 genomes]
rs9393691	0.83[AFR][1000 genomes];0.87[AMR][1000 genomes];0.95[EUR][1000 genomes];0.83[ASN][1000 genomes]
rs9393696	0.88[AFR][1000 genomes];0.91[AMR][1000 genomes];0.96[EUR][1000 genomes]
rs9393697	0.86[AFR][1000 genomes];0.91[AMR][1000 genomes];0.97[EUR][1000 genomes];0.80[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:10 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1029920	chr6:25638507-26585842	Bivalent/Poised TSS Flanking Active TSS ZNF genes & repeats Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Active TSS Genic enhancers Strong transcription Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	1215 gene(s)	inside rSNPs	diseases
2	nsv538162	chr6:25638507-26585842	Flanking Active TSS Active TSS ZNF genes & repeats Genic enhancers Weak transcription Strong transcription Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	1215 gene(s)	inside rSNPs	diseases
3	nsv1030351	chr6:25813178-26352046	Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	1189 gene(s)	inside rSNPs	diseases
4	nsv1023453	chr6:25853830-26528250	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Strong transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	1201 gene(s)	inside rSNPs	diseases
5	nsv428137	chr6:25987413-26351920	Enhancers Flanking Active TSS Active TSS Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	1181 gene(s)	inside rSNPs	diseases
6	nsv1018665	chr6:26026870-26352046	Flanking Active TSS Weak transcription Active TSS Enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	1116 gene(s)	inside rSNPs	diseases
7	nsv482729	chr6:26291011-26470898	Weak transcription Active TSS Flanking Active TSS Enhancers Strong transcription Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	45 gene(s)	inside rSNPs	diseases
8	nsv5230	chr6:26321593-26361531	Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	32 gene(s)	inside rSNPs	diseases
9	esv3521788	chr6:26334022-26356973	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	17 gene(s)	inside rSNPs	diseases
10	esv3521789	chr6:26334022-26356973	Weak transcription Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	17 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:31 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:26332400-26336000	Weak transcription	HSMMtube	muscle
2	chr6:26332600-26336200	Weak transcription	HSMM	muscle
3	chr6:26332600-26336400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
4	chr6:26333000-26336000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
5	chr6:26333000-26336000	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
6	chr6:26333000-26336000	Weak transcription	Osteobl	bone
7	chr6:26333000-26336200	Weak transcription	NH-A	brain
8	chr6:26333000-26336200	Weak transcription	NHLF	lung
9	chr6:26333000-26336400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
10	chr6:26333000-26337200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
11	chr6:26333000-26341600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
12	chr6:26333000-26342200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
13	chr6:26333200-26336000	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
14	chr6:26333200-26336000	Weak transcription	GM12878-XiMat	blood
15	chr6:26333200-26336000	Weak transcription	NHEK	skin
16	chr6:26333200-26336400	Weak transcription	HMEC	breast
17	chr6:26334600-26336200	Enhancers	K562	blood
18	chr6:26335600-26336200	Enhancers	H9 Cell Line	embryonic stem cell
19	chr6:26335600-26336400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
20	chr6:26335600-26336400	Enhancers	A549	lung
21	chr6:26335600-26336400	Enhancers	Hela-S3	cervix
22	chr6:26335600-26337400	Enhancers	HepG2	liver
23	chr6:26335600-26337600	Enhancers	HUES6 Cell Line	embryonic stem cell
24	chr6:26335800-26336200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
25	chr6:26335800-26336600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
26	chr6:26335800-26337000	Enhancers	Primary T helper naive cells fromperipheralblood	blood
27	chr6:26335800-26337200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
28	chr6:26335800-26337400	Enhancers	ES-I3 Cell Line	embryonic stem cell
29	chr6:26335800-26337400	Enhancers	HUES48 Cell Line	embryonic stem cell
30	chr6:26335800-26337600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
31	chr6:26335800-26337600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links